维普期刊资源整合服务平台（V6.5）

739篇 您的检索式：作者名="Yellon DM"

选中清除导出查看参考文献查看引证文献引用追踪共37页首页上一页第1页下一页末页 /37 跳转

	题名	作者	年代	出处	被引量
1	New directions for protecting the heart against ischemia-reperfusion injury:targeting the reperfusion injury salvage kinase (RISK)-pathway显示文摘	Hausenloy DJ Yellon DM	2004	Cardiovasc Res2004，61，3：	1
2	B- type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening 显示文摘	D'Souza SP Yellon DM Martin C	2003	Am J Physiol Heart Circ Physiol2003，284，5：	1
3	Chronic erythropoietin treatment limits infarct-size in the myocardium in vitro显示文摘	Bullard AJ Yellon DM	2005	Cardiovasc Drugs Ther2005，19，5：	1
4	Conditioning the whole heart-not just the eardiomyocyte显示文摘	Bell RM Yellon DM	2012	J Mol Cell Cardiol2012，53，1：	1
5	Controversies in the cardiovas- cular management of type 2 diabetes 显示文摘	Opie LH Yellon DM Gersh BJ	2011	Heart2011，97，1：	1
6	The preconditioning phenomenon: atool for the scientist or a clinical reality 显示文摘	Yellon DM Dana A	2000	Circ Res2000，87，7：	1
7	B-type natriuretic peplidc limits inthrct size in tat isolated hearts via KATP channel opening 显示文摘	D Souza SP Yellon DM Martin CM	2003	Am J Physiol Heart cire Physiol2003，284，5：	1
8	Wake up and smell the coffee:yet another no go for cardiac patients:editorial to'caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat' by Ye et al显示文摘	Riksen NP Hausenloy DJ Yellon DM		0，，04：	1
9	New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase ( RISK )-pathway 显示文摘	Hausenloy DJ Yellon DM	2004	Cardiovasc Res2004，61，3：	1
10	Peri-procedural myocardial injury during percutaneous coronary intervention:an important target for cardioprotection显示文摘	Babu GG Walker JM Yellon DM	2010	Eur Heart J2010，32，1：	1
11	Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels 显示文摘	Hausenloy D J Yellon DM	2008	Heart2008，94，6：	1
12	Preconditioning the human myocardium显示文摘	Yellon DM Alkhulaifi AM Pugsley WB	1993	Lancet1993，342，：	1
13	Erythropoietin:ready for prime-time cardioprotcction 显示文摘	Riksen NP Hausenloy DJ Yellon DM	2008	Trends Pharmacol Sci2008，29，5：	1
14	Insulin therapy as an adjunct to repeifusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation 显示文摘	Sack MN Yellon DM	2003	J Am Coil Cardiol2003，41，8：	1
15	Inhibiting mitochondrial per- meability l ore opening at reperfusion protects against ischemia-reperfu- sion injury显示文摘	Hausenloy KJ Duchen MR Yellon DM	2003	Cardiovasc Res2003，60，3：	1
16	Myocardial reperfusion injury显示文摘	Yellon DM Hausenloy DJ	2007	N Engl J Med2007，357，11：	1
17	Preconditioning and postcondi- tioning: united at reperfusion 显示文摘	HAUSENLOY DJ YELLON DM	2007	Pharmacol Ther2007，116，2：	1
18	The mitochondrial permeability transition pore:its fundamental role in mediating cell death during ischaemia and reperfusion显示文摘	Hausenloy DJ Yellon DM	2003	J Mol Cell Cardiol2003，35，4：	1
19	Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide显示文摘	Maddock HL Siedlecka SM Yellon DM	2004	Cardiovasc Drugs Ther2004，18，2：	1
20	Cross-talk between the survival kinases during early reperfusion:its contribution to ischemic preconditioning显示文摘	Hausenloy DJ Mocanu MM Yellon DM	2004	Cardiovasc Res2004，63，：	1

返回顶部每页显示：

共37页首页上一页第1页下一页末页 /37 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示